Novartis Ag (NVSEF) Net Margin Growth (1y) (2014 - 2025)
Novartis Ag (NVSEF) Net Margin Growth (1y) (2014 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (1y) (Qtr) |
| 1 |
Gsk |
93,699,046.73 Bn |
93,699,041.77 Bn |
7.76 Bn |
116.00 |
| 2 |
Eli Lilly |
1,012.06 Bn |
1,006.77 Bn |
16.22 Bn |
1,568.00 |
| 3 |
Johnson & Johnson |
560.67 Bn |
538.62 Bn |
15.96 Bn |
-2,848.00 |
| 4 |
AbbVie |
402.20 Bn |
392.85 Bn |
10.78 Bn |
-501.00 |
| 5 |
Merck |
298.59 Bn |
292.94 Bn |
12.09 Bn |
-5,859.00 |
| 6 |
Amgen |
188.77 Bn |
176.74 Bn |
5.87 Bn |
-12.00 |
| 7 |
Gilead Sciences |
160.22 Bn |
152.49 Bn |
5.52 Bn |
931.00 |
| 8 |
Pfizer |
148.19 Bn |
135.42 Bn |
-1.21 Bn |
- |
| 9 |
Bristol Myers Squibb |
116.72 Bn |
106.26 Bn |
8.07 Bn |
134.00 |
| 10 |
Novartis Ag |
- |
- |
- |
- |
| Date | Value |
|---|
| Jun 30, 2025 |
154.00 |
| Dec 31, 2024 |
2,778.00 |
| Jun 30, 2024 |
3,030.00 |
| Dec 31, 2023 |
-5,859.00 |
| Jun 30, 2023 |
-1,557.00 |
| Mar 31, 2023 |
-18,707.00 |
| Dec 31, 2022 |
3,597.00 |
| Sep 30, 2022 |
-18,026.00 |
| Jun 30, 2022 |
-1,108.00 |
| Mar 31, 2022 |
4,860.00 |
| Dec 31, 2021 |
-200,503.00 |
| Sep 30, 2021 |
3,029.00 |
| Jun 30, 2021 |
690.00 |
| Mar 31, 2021 |
10,175.00 |
| Jun 30, 2020 |
-1,971.00 |
| Mar 31, 2020 |
12,415.00 |
| Jun 30, 2019 |
3,957.00 |
| Mar 31, 2019 |
-7,034.00 |
| Dec 31, 2018 |
-26,536.00 |
| Sep 30, 2018 |
-40,691.00 |
